Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
1
|
| pubmed:dateCreated |
1969-1-8
|
| pubmed:language |
ita
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:chemical | |
| pubmed:status |
MEDLINE
|
| pubmed:month |
Feb
|
| pubmed:issn |
0015-5535
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
21
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
18-30
|
| pubmed:dateRevised |
2011-11-17
|
| pubmed:meshHeading |
pubmed-meshheading:5754871-Blood Glucose,
pubmed-meshheading:5754871-Glucagon,
pubmed-meshheading:5754871-Glucose,
pubmed-meshheading:5754871-Humans,
pubmed-meshheading:5754871-Hyperthyroidism,
pubmed-meshheading:5754871-Injections, Intravenous,
pubmed-meshheading:5754871-Insulin,
pubmed-meshheading:5754871-Myxedema
|
| pubmed:year |
1968
|
| pubmed:articleTitle |
[Immunoreactive plasmatic insulin (IRI) in hyperthyreosis and myxedema. Effects of glucose and glucagon in intravenous injection].
|
| pubmed:publicationType |
Journal Article
|